Delivery Order SPE2DB22D2006-SPE2DB25FV9RX

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.08, is for the delivery of atovaquone-proguanil 250-100 mg, a pharmaceutical product used for the prevention and treatment of malaria. The contract is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025. This award is not a set-aside contract,...
This federal contract award, valued at $3,134.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of atovaquone-proguanil 250-100 100s, a medication used for the treatment and prevention of malaria. The contract is a Firm Fixed Price Delivery Order with a period of performance extending through May 9, 2025. This award is not designated as a set-aside contract,...
This is a $225,650.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a malaria medication, with an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This contract award, valued at $6,608.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Atovaquone-Proguanil 250-100 100S, a medication used for the prevention and treatment of malaria. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.30, is for the delivery of atovaquone-proguanil 250-100 100s, a medical product used for the prevention and treatment of malaria. The contract is a firm fixed-price, indefinite delivery vehicle that runs through January 17, 2025. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,056.83, is for the delivery of atovaquone-proguanil 250-100 mg tablets, a prescription medication used to prevent and treat malaria. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,307.16, is a Firm Fixed Price Delivery Order for the procurement of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for malaria prevention and treatment. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.86 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a prescription medication used for the prevention and treatment of malaria. The contract has an ultimate completion date of March 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $112,825.44 Firm Fixed Price Delivery Order is for the supply of Atovaquone-Proguanil 250-100 100s, a medication used for the prevention and treatment of malaria. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,862.01 delivery order contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria preventative medication. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV9RX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,171.23, is for the delivery of Atovaquone-Proguanil 250-100 100s, a prescription medication used for the prevention and treatment of malaria. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/2/25, 10:27 PM